Our Services

Clinical protocol managment

Turnkey study including ethical forms, writing, insurance forms...

Get Started

Human cell cultures

Human cell cultures are set according to your targeted organ or pathology

Get Started

Publication writing

We handle the scientific writing and the publication of your data for your communication

Get Started
image
image
image
image

Our Team

Gathering skills for your clinical research

image
image
💪🧬🥇NOW 7 INTERNATIONAL PUBLICATIONS (and more to come) TO ATTEST THE ROBUSTNESS AND EFFICIENCY OF EX VIVO CLINICAL APPROACH – CLINIC’N’CELL

https://pubmed.ncbi.nlm.nih.gov/37111121/

Nutrients 2023 Apr 14;15(8):1903. doi: 10.3390/nu15081903.

Circulating Human Metabolites Resulting from TOTUM-070 Absorption (a Plant-Based, Polyphenol-Rich Ingredient) Improve Lipid Metabolism in Human Hepatocytes: Lessons from an Original Ex Vivo Clinical Trial

Fabien Wauquier 1Line Boutin-Wittrant 1Stéphanie Krisa 2Josep Valls 2 3Cedric Langhi 4Yolanda F Otero 4Pascal Sirvent 4Sébastien Peltier 5Maxime Bargetto 5Murielle Cazaubiel 5Véronique Sapone 5Annie Bouchard-Mercier 6Véronique Roux 7Nicolas Macian 7Gisèle Pickering 7Yohann Wittrant 8 9

clinicncell / clinic’n’cell

# EX VIVO CLINICAL TRIAL

https://www.ahajournals.org/doi/abs/10.1161/circ.146.suppl_1.11397?af=R

This clinical innovative approach provides robust human data regarding the health benefits of a product in faster, more affordable and more mechanistic ways (mode of action in humans) than any conventional clinical trial. Using human metabolites (circulating and bioavailable bioactives) this approach is more physiological than any in vitro test. The approach is also intended to be ethical since it allow to get rid of an animal experimentation. #clinicncell #clinic’n’cell

AND ONE MORE PUBLICATION… FOR CLINICNCELL = NOW 6 INTERNATIONAL PEER REVIEWED MANUSCRITS AND ONGOING

https://pubmed.ncbi.nlm.nih.gov/36501057/

Nutrients 2022 Nov 25;14(23):5027. doi: 10.3390/nu14235027

Benefits of Circulating Human Metabolites from Fish Cartilage Hydrolysate on Primary Human Dermal Fibroblasts, an Ex Vivo Clinical Investigation for Skin Health Applications.

Fabien Wauquier 1Line Boutin-Wittrant 1Elodie Bouvret 2Julie Le Faouder 2Véronique Roux 3Nicolas Macian 3Gisèle Pickering 3Yohann Wittrant 4 5

ClinicnCell

🍾 🏆 🥇🔬CLINIC’N’CELL SAS has just obtained the renewal of its CIR approval for 2023 – 2024 and 2025. A great recognition from the General Direction of Research and Innovation of the French Ministry of Higher Education and Research

This clinical innovation provides robust human data regarding the health benefits of a product in faster, more affordable and more mechanistic ways (mode of action in humans) than any conventional clinical trial. Using human metabolites (circulating and bioavailable bioactives) this approach is more physiological than any in vitro test. The approach is also intended to be ethical since it allow to get rid of an animal experimentation. #clinicncell #clinic’n’cell

CLINICNCELL sponsors and participates to the European Calcified Tissue Society PhD Training Course 2022

This prestigious PhD Training Course, aimed at promoting general knowledge of bone research to young investigators, is now in its 15th year and has been hailed as one of the most innovative and successful courses in the bone field.

The course starts with an “introductory session” where key topics relevant to skeletal research are covered, followed by a varied programme that incorporates clinical and basic topics with a mix of speakers with clinical or basic science backgrounds. An example of the topics likely to be included in the programme is provided below. One of the important aspects of the course is the opportunity for students to network and obtain feedback on their project. Student presentations include poster and short presentations of their PhD project as well as networking sessions with invited speakers. The course has been of immense value to previous participants, and the networks that form during these events help to sustain the musculoskeletal field in Europe into the future.